$2.49T
Total marketcap
$64.46B
Total volume
BTC 50.80%     ETH 15.09%
Dominance

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. ANGEN.IS Stock

13.8 TRY {{ price }} -0.216918% {{change_pct}}%
COUNTRY
Turkey
Exchange
Istanbul
Market Cap
3.14B TRY
LOW - HIGH [24H]
13.55 - 13.89 TRY
VOLUME [24H]
926.31K TRY
{{ volume }}
P/E Ratio
0
Earnings per share
-0.83 TRY

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Price Chart

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. ANGEN.IS Financial and Trading Overview

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. stock price 13.8 TRY
Previous Close 12.75 TRY
Open 12.76 TRY
Bid 12.83 TRY x N/A
Ask 12.86 TRY x N/A
Day's Range 12.76 - 13.04 TRY
52 Week Range 9.23 - 25.03 TRY
Volume 491.16K TRY
Avg. Volume 3.33M TRY
Market Cap 2.82B TRY
Beta (5Y Monthly) N/A
PE Ratio (TTM) 16.253164
EPS (TTM) -0.83 TRY
Forward Dividend & Yield 0.6 (4.53%)
Ex-Dividend Date May 3, 2023
1y Target Est N/A

ANGEN.IS Valuation Measures

Enterprise Value 2.36B TRY
Trailing P/E 16.253164
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 16.51471
Price/Book (mrq) 3.3789475
Enterprise Value/Revenue 13.774
Enterprise Value/EBITDA 41.236

Trading Information

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 2.32%
S&P500 52-Week Change 20.43%
52 Week High 25.03 TRY
52 Week Low 9.23 TRY
50-Day Moving Average 12.17 TRY
200-Day Moving Average 15.93 TRY

ANGEN.IS Share Statistics

Avg. Volume (3 month) 3.33M TRY
Avg. Daily Volume (10-Days) 2.91M TRY
Shares Outstanding 220M
Float 55.81M
Short Ratio N/A
% Held by Insiders 74.67%
% Held by Institutions 0.24%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0.596
Trailing Annual Dividend Yield 4.67%
5 Year Average Dividend Yield N/A
Payout Ratio 1.7080001
Last Split Factor 200:100

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 104.59%
Operating Margin (ttm) 18.29%
Gross Margin 78.42%
EBITDA Margin 33.40%

Management Effectiveness

Return on Assets (ttm) N/A
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 171.05M TRY
Revenue Per Share (ttm) 0.78 TRY
Quarterly Revenue Growth (yoy) -78.29%
Gross Profit (ttm) 224.3M TRY
EBITDA 57.14M TRY
Net Income Avi to Common (ttm) 178.9M TRY
Diluted EPS (ttm) 0.79
Quarterly Earnings Growth (yoy) -92.70%

Balance Sheet

Total Cash (mrq) 448.6M TRY
Total Cash Per Share (mrq) 2.04 TRY
Total Debt (mrq) 12.9M TRY
Total Debt/Equity (mrq) 1.54 TRY
Current Ratio (mrq) 19.946
Book Value Per Share (mrq) 3.8

Cash Flow Statement

Operating Cash Flow (ttm) 95.56M TRY
Levered Free Cash Flow (ttm) N/A

Profile of Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.

Country Turkey
State N/A
City Istanbul
Address Hasanpasa Mah.
ZIP 34920
Phone 90 216 330 04 55
Website https://www.anatoliageneworks.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 150

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cytomegalovirus, crimean-congo hemorrhagic fever, novel coronavirus (2019-NCoV)/SARS-CoV-2, epstein-barr virus, hepatitis B, hepatitis C, hepatitis D, herpes simplex virus, human immunodeficiency virus, human papillomavirus, JC and BK polyomaviruses, malaria, measles, meningitis, respiratory infection, parvovirus B19, torque teno virus, toxoplasmosis, tuberculosis, ureaplasma, and west nile virus diseases, as well as factor II, factor V leiden, and methylene-tetra-hydro-folate-reductase mutation diseases. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is headquartered in Istanbul, Turkey.

Q&A For Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Stock

What is a current ANGEN.IS stock price?

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. ANGEN.IS stock price today per share is 13.8 TRY.

How to purchase Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. stock?

You can buy ANGEN.IS shares on the Istanbul exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.?

The stock symbol or ticker of Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. is ANGEN.IS.

Which industry does the Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. company belong to?

The Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. industry is Medical Devices.

How many shares does Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. have in circulation?

The max supply of Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. shares is 227.4M.

What is Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. Price to Earnings Ratio (PE Ratio)?

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. PE Ratio is now.

What was Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. earnings per share over the trailing 12 months (TTM)?

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. EPS is -0.83 TRY over the trailing 12 months.

Which sector does the Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. company belong to?

The Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. sector is Healthcare.